MannKind Corp (MNKD)
4.40
+0.01
(+0.23%)
USD |
NASDAQ |
May 06, 16:00
4.39
-0.01
(-0.23%)
After-Hours: 20:00
MannKind Revenue (Annual): 198.96M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 198.96M |
| December 31, 2022 | 99.77M |
| December 31, 2021 | 75.44M |
| December 31, 2020 | 65.14M |
| December 31, 2019 | 63.04M |
| December 31, 2018 | 27.86M |
| December 31, 2017 | 11.74M |
| December 31, 2016 | 174.76M |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | 0.035M |
| Date | Value |
|---|---|
| December 31, 2011 | 0.05M |
| December 31, 2010 | 0.093M |
| December 31, 2009 | |
| December 31, 2008 | 0.02M |
| December 31, 2007 | 0.01M |
| December 31, 2006 | 0.10M |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | 0.326M |
| December 31, 2000 | 0.154M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
63.04M
Minimum
2019
198.96M
Maximum
2023
100.47M
Average
75.44M
Median
2021
Revenue (Annual) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.854M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |